Guttorm Raknes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Guttorm Raknes has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Lars Småbrekke
Department of Pharmacy, UIT The Arctic University of Norway, Tromsø, Norway
5 shared publications Steinar Hunskår
4 shared publicationsLars Småbrekke
Department of Pharmacy, Faculty of Health Sciences, UiT – The Arctic University of Norway, Tromsø, Norway
3 shared publications- Marianne Sørlie Strøm
Department of Health Registry Research and Development, Norwegian Institute of Public Health, Bergen, Norway
3 shared publications Trude Giverhaug
3 shared publications- Christian A. Vedeler
Department of Neurology, University of Bergen, Norway
2 shared publications
Latest Publications
- Open Access
- 12 December 2024
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 144 (15)
Protonpumpehemmarar mot spiserørskreft – til nytte eller skade?
12.12.2024: Kronikk - Førekomsten av spiserørskreft i Noreg har auka parallelt med aukande forbruk av protonpumpehemmarar.
- 12 December 2024
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 144 (15)
Open AccessProtonpumpehemmarar mot spiserørskreft – til nytte eller skade?
12.12.2024: Kronikk - Førekomsten av spiserørskreft i Noreg har auka parallelt med aukande forbruk av protonpumpehemmarar.
- Open Access
- 22 January 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-13
Excess non-COVID-19 mortality in Norway 2020–2022
Background: Causes of death other than COVID-19 seem to contribute significantly to the excess mortality observed during the 2020–2022 pandemic. In this study, we explore changes in non-COVID-19 causes of death in Norway during the COVID-19 pandemic from March 2020 to December 2022. Methods: We performed a population-based cross-sectional study on data from the Norwegian Cause of Death Registry. All recorded deaths from 1st January 2010 to 31st December 2022 were included. The main outcome measures were the number of deaths and age-standardised death rate (ASMR) per 100000 population from the major cause of death groups in 2020, 2021 and 2022. The predicted number of deaths and ASMRs were forecasted with a 95% prediction interval constructed from a general linear regression model based on the corresponding number of deaths and rates from the preceding ten prepandemic years (2010–2019). We also examined whether there were deviations from expected seasonality in the pandemic period based on prepandemic monthly data from 2010–2019. The cumulative number of deaths and ASMR were estimated based on monthly mortality data. Results: There was significant excess mortality (number of deaths) in 2021 and 2022 for all causes (3.7% and 14.5%), for cardiovascular diseases (14.3% and 22.0%), and for malignant tumours in 2022 (3.5%). In terms of ASMR, there was excess mortality in 2021 and 2022 for all causes (2.9% and 13.7%), and for cardiovascular diseases (16.0% and 25,8%). ASMR was higher than predicted in 2022 for malignant tumours (2.3%). There were fewer deaths than predicted from respiratory diseases (except COVID-19) in 2020 and 2021, and from dementia in 2021 and 2022. From March 2020 to December 2022, there were cumulatively 3754 (ASMR 83.8) more non-COVID-19 deaths than predicted, of which 3453 (ASMR: 79.6) were excess deaths from cardiovascular disease, 509 (ASMR 4.0) from malignant tumours. Mortality was lower than predicted for respiratory diseases (-1889 (ASMR: -44.3)), and dementia (-530 (ASMR -18.5)). Conclusions: There was considerable excess non-COVID-19 mortality in Norway from March 2020 until December 2022, mainly due to excess cardiovascular deaths. For respiratory diseases and dementia, mortality was lower than predicted.
- 22 January 2024
- Published by Springer Nature in BMC Public Health
- Vol. 24 (1) , 1-13
Open AccessExcess non-COVID-19 mortality in Norway 2020–2022
Background: Causes of death other than COVID-19 seem to contribute significantly to the excess mortality observed during the 2020–2022 pandemic. In this study, we explore changes in non-COVID-19 causes of death in Norway during the COVID-19 pandemic from March 2020 to December 2022. Methods: We performed a population-based cross-sectional study on data from the Norwegian Cause of Death Registry. All recorded deaths from 1st January 2010 to 31st December 2022 were included. The main outcome measures were the number of deaths and age-standardised death rate (ASMR) per 100000 population from the major cause of death groups in 2020, 2021 and 2022. The predicted number of deaths and ASMRs were forecasted with a 95% prediction interval constructed from a general linear regression model based on the corresponding number of deaths and rates from the preceding ten prepandemic years (2010–2019). We also examined whether there were deviations from expected seasonality in the pandemic period based on prepandemic monthly data from 2010–2019. The cumulative number of deaths and ASMR were estimated based on monthly mortality data. Results: There was significant excess mortality (number of deaths) in 2021 and 2022 for all causes (3.7% and 14.5%), for cardiovascular diseases (14.3% and 22.0%), and for malignant tumours in 2022 (3.5%). In terms of ASMR, there was excess mortality in 2021 and 2022 for all causes (2.9% and 13.7%), and for cardiovascular diseases (16.0% and 25,8%). ASMR was higher than predicted in 2022 for malignant tumours (2.3%). There were fewer deaths than predicted from respiratory diseases (except COVID-19) in 2020 and 2021, and from dementia in 2021 and 2022. From March 2020 to December 2022, there were cumulatively 3754 (ASMR 83.8) more non-COVID-19 deaths than predicted, of which 3453 (ASMR: 79.6) were excess deaths from cardiovascular disease, 509 (ASMR 4.0) from malignant tumours. Mortality was lower than predicted for respiratory diseases (-1889 (ASMR: -44.3)), and dementia (-530 (ASMR -18.5)). Conclusions: There was considerable excess non-COVID-19 mortality in Norway from March 2020 until December 2022, mainly due to excess cardiovascular deaths. For respiratory diseases and dementia, mortality was lower than predicted.
- Open Access
- 23 October 2023
- Published by Springer Nature in Research Square
Non-COVID-19 deaths in Norway 2020–2022. A population-based cross-sectional register study
Background Causes of death other than COVID-19 seem to contribute significantly to the excess mortality observed during the 2020–2022 pandemic. In this study, we explore changes in non-COVID-19 causes of death in Norway during the COVID-19 pandemic from March 2020 to December 2022. Methods We performed a population-based cross-sectional study on data from the Norwegian Cause of Death Registry. All recorded deaths from 1st January 2010 to 31st December 2022 were included. The main outcome measures were the number of deaths and age-standardised death rate (ASMR) per 100000 population from the major cause of death groups in 2020, 2021 and 2022. The predicted number of deaths and ASMRs were forecasted with a 95% prediction interval constructed from a general linear regression model based on the corresponding number of deaths and rates from the preceding ten prepandemic years (2010–2019). We also examined whether there were deviations from expected seasonality in the pandemic period based on prepandemic monthly data from 2010–2019. The cumulative number of deaths and ASMR were estimated based on monthly mortality data. Results There was significant excess mortality (number of deaths) in 2021 and 2022 for all causes (3.7% and 14.5%), for cardiovascular diseases (14.3% and 22.0%), and for malignant tumours in 2022 (3.5%). In terms of ASMR, there was excess mortality in 2021 and 2022 for all causes (2.9% and 13.7%), and for cardiovascular diseases (16.0% and 25,8%). ASMR was higher than predicted in 2022 for malignant tumours (2.3%). There were fewer deaths than predicted from respiratory diseases (except COVID-19) in 2020 and 2021, and from dementia in 2021 and 2022. From March 2020 to December 2022, there were cumulatively 3754 (ASMR 83.8) more non-COVID-19 deaths than predicted, of which 3453 (ASMR: 79.6) were excess deaths from cardiovascular disease, 509 (ASMR 4.0) from malignant tumours. Mortality was lower than predicted for respiratory diseases (-1889 (ASMR: -44.3)), and dementia (-530 (ASMR − 18.5)). Conclusions There was considerable excess non-COVID-19 mortality in Norway from March 2020 until December 2022, mainly due to excess cardiovascular deaths. For respiratory diseases and dementia, mortality was lower than predicted.
- 23 October 2023
- Published by Springer Nature in Research Square
Open AccessNon-COVID-19 deaths in Norway 2020–2022. A population-based cross-sectional register study
Background Causes of death other than COVID-19 seem to contribute significantly to the excess mortality observed during the 2020–2022 pandemic. In this study, we explore changes in non-COVID-19 causes of death in Norway during the COVID-19 pandemic from March 2020 to December 2022. Methods We performed a population-based cross-sectional study on data from the Norwegian Cause of Death Registry. All recorded deaths from 1st January 2010 to 31st December 2022 were included. The main outcome measures were the number of deaths and age-standardised death rate (ASMR) per 100000 population from the major cause of death groups in 2020, 2021 and 2022. The predicted number of deaths and ASMRs were forecasted with a 95% prediction interval constructed from a general linear regression model based on the corresponding number of deaths and rates from the preceding ten prepandemic years (2010–2019). We also examined whether there were deviations from expected seasonality in the pandemic period based on prepandemic monthly data from 2010–2019. The cumulative number of deaths and ASMR were estimated based on monthly mortality data. Results There was significant excess mortality (number of deaths) in 2021 and 2022 for all causes (3.7% and 14.5%), for cardiovascular diseases (14.3% and 22.0%), and for malignant tumours in 2022 (3.5%). In terms of ASMR, there was excess mortality in 2021 and 2022 for all causes (2.9% and 13.7%), and for cardiovascular diseases (16.0% and 25,8%). ASMR was higher than predicted in 2022 for malignant tumours (2.3%). There were fewer deaths than predicted from respiratory diseases (except COVID-19) in 2020 and 2021, and from dementia in 2021 and 2022. From March 2020 to December 2022, there were cumulatively 3754 (ASMR 83.8) more non-COVID-19 deaths than predicted, of which 3453 (ASMR: 79.6) were excess deaths from cardiovascular disease, 509 (ASMR 4.0) from malignant tumours. Mortality was lower than predicted for respiratory diseases (-1889 (ASMR: -44.3)), and dementia (-530 (ASMR − 18.5)). Conclusions There was considerable excess non-COVID-19 mortality in Norway from March 2020 until December 2022, mainly due to excess cardiovascular deaths. For respiratory diseases and dementia, mortality was lower than predicted.
- Open Access
- 11 July 2022
- Published by Taylor & Francis in Scandinavian Journal of Primary Health Care
- Vol. 40 (2) , 281-288
How often do nurses suspect violence and domestic violence in local emergency medical communication centre? A cross-sectional study
To assess the extent of violence that is revealed by screening at first contact with a local out-of-hours emergency medical communication centre (LEMC; Norwegian ‘Legevaktsentral’).Cross-sectional ...
- 11 July 2022
- Published by Taylor & Francis in Scandinavian Journal of Primary Health Care
- Vol. 40 (2) , 281-288
Open AccessHow often do nurses suspect violence and domestic violence in local emergency medical communication centre? A cross-sectional study
To assess the extent of violence that is revealed by screening at first contact with a local out-of-hours emergency medical communication centre (LEMC; Norwegian ‘Legevaktsentral’).Cross-sectional ...
- Open Access
- 19 April 2022
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 65 (1) , 1-24
Suicide trends in Norway during the first year of the COVID-19 pandemic: A register-based cohort study
Background: There is a concern that the COVID-19 pandemic will lead to an increase in suicides. Several reports from the first months of the pandemic showed no increase in suicide rates while studies with longer observation times report contrasting results. In this study, we explore the suicide rates in Norway during the first year of the pandemic for the total population as well as for relevant subgroups such as sex, age, geographical areas, and pandemic phases.Methods: This is a cohort study covering the entire Norwegian population between 2010 and 2020. The main outcome was age-standardized suicide rates (per 100,000 inhabitants) in 2020 according to the Norwegian Cause of Death Registry. This was compared with 95% prediction intervals (95% PI) based on the suicide rates between 2010 and 2019.Results: In 2020, there were 639 suicides in Norway corresponding to a rate of 12.1 per 100,000 (95% PI 10.2–14.4). There were no significant deviations from the predicted values for suicides in 2020 when analyzing age, sex, pandemic phase, or geographical area separately. We observed a trend toward a lower than predicted suicide rate among females (6.5, 95% PI 6.0–9.2), and during the two COVID-19 outbreak phases in 2020 (2.8, 95% PI 2.3–4.3 and 2.8, 95% CI 2.3–4.3).Conclusion: There is no indication that the COVID-19 pandemic led to an increase in suicide rates in Norway in 2020.
- 19 April 2022
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 65 (1) , 1-24
Open AccessSuicide trends in Norway during the first year of the COVID-19 pandemic: A register-based cohort study
Background: There is a concern that the COVID-19 pandemic will lead to an increase in suicides. Several reports from the first months of the pandemic showed no increase in suicide rates while studies with longer observation times report contrasting results. In this study, we explore the suicide rates in Norway during the first year of the pandemic for the total population as well as for relevant subgroups such as sex, age, geographical areas, and pandemic phases.Methods: This is a cohort study covering the entire Norwegian population between 2010 and 2020. The main outcome was age-standardized suicide rates (per 100,000 inhabitants) in 2020 according to the Norwegian Cause of Death Registry. This was compared with 95% prediction intervals (95% PI) based on the suicide rates between 2010 and 2019.Results: In 2020, there were 639 suicides in Norway corresponding to a rate of 12.1 per 100,000 (95% PI 10.2–14.4). There were no significant deviations from the predicted values for suicides in 2020 when analyzing age, sex, pandemic phase, or geographical area separately. We observed a trend toward a lower than predicted suicide rate among females (6.5, 95% PI 6.0–9.2), and during the two COVID-19 outbreak phases in 2020 (2.8, 95% PI 2.3–4.3 and 2.8, 95% CI 2.3–4.3).Conclusion: There is no indication that the COVID-19 pandemic led to an increase in suicide rates in Norway in 2020.
- Open Access
Lockdown and non-COVID-19 deaths: cause-specific mortality during the first wave of the 2020 pandemic in Norway: a population-based register study
Objective To explore the potential impact of the first wave of COVID-19 pandemic on all cause and cause-specific mortality in Norway. Design Population-based register study. Setting The Norwegian cause of Death Registry and the National Population Register of Norway. Participants All recorded deaths in Norway from March to May from 2010 to 2020. Main outcome measures Rate (per 100 000) of all-cause mortality and causes of death in the European Shortlist for Causes of Death from March to May 2020. The rates were age standardised and adjusted to a 100% register coverage and compared with a 95% prediction interval (PI) from linear regression based on corresponding rates for 2010–2019. Results 113 710 deaths were included, of which 10 226 were from 2020. We did not observe any deviation from predicted total mortality. There were fewer than predicted deaths from chronic lower respiratory diseases excluding asthma (11.4, 95% PI 11.8 to 15.2) and from other non-ischaemic, non-rheumatic heart diseases (13.9, 95% PI 14.5 to 20.2). The death rates were higher than predicted for Alzheimer’s disease (7.3, 95% PI 5.5 to 7.3) and diabetes mellitus (4.1, 95% PI 2.1 to 3.4). Conclusions There was no significant difference in the frequency of the major causes of death in the first wave of the 2020 COVID-19 pandemic in Norway compared with corresponding periods 2010–2019. There was an increase in diabetes mellitus and Alzheimer’s deaths. Reduced mortality due to some heart and lung conditions may be linked to infection control measures.
Open AccessLockdown and non-COVID-19 deaths: cause-specific mortality during the first wave of the 2020 pandemic in Norway: a population-based register study
Objective To explore the potential impact of the first wave of COVID-19 pandemic on all cause and cause-specific mortality in Norway. Design Population-based register study. Setting The Norwegian cause of Death Registry and the National Population Register of Norway. Participants All recorded deaths in Norway from March to May from 2010 to 2020. Main outcome measures Rate (per 100 000) of all-cause mortality and causes of death in the European Shortlist for Causes of Death from March to May 2020. The rates were age standardised and adjusted to a 100% register coverage and compared with a 95% prediction interval (PI) from linear regression based on corresponding rates for 2010–2019. Results 113 710 deaths were included, of which 10 226 were from 2020. We did not observe any deviation from predicted total mortality. There were fewer than predicted deaths from chronic lower respiratory diseases excluding asthma (11.4, 95% PI 11.8 to 15.2) and from other non-ischaemic, non-rheumatic heart diseases (13.9, 95% PI 14.5 to 20.2). The death rates were higher than predicted for Alzheimer’s disease (7.3, 95% PI 5.5 to 7.3) and diabetes mellitus (4.1, 95% PI 2.1 to 3.4). Conclusions There was no significant difference in the frequency of the major causes of death in the first wave of the 2020 COVID-19 pandemic in Norway compared with corresponding periods 2010–2019. There was an increase in diabetes mellitus and Alzheimer’s deaths. Reduced mortality due to some heart and lung conditions may be linked to infection control measures.
- 16 August 2021
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 141 (11)
G. Raknes svarer
- 16 August 2021
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 141 (11)
G. Raknes svarer
- 16 August 2021
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 141 (11)
Progestageners terminologi - en presisering
- 16 August 2021
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 141 (11)
Progestageners terminologi - en presisering
- 21 June 2021
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 141 (11)
Rettelse: Progestageners terminologi
21.06.2021: Rettelse - Tidsskr Nor Legeforen 2021; 141: 883.
- 21 June 2021
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 141 (11)
Rettelse: Progestageners terminologi
21.06.2021: Rettelse - Tidsskr Nor Legeforen 2021; 141: 883.
- 7 June 2021
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 141 (9)
Progestageners terminologi
07.06.2021: Språkspalten - Progestagene hormoners terminologi er kompleks.
- 7 June 2021
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 141 (9)
Progestageners terminologi
07.06.2021: Språkspalten - Progestagene hormoners terminologi er kompleks.